Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a High Risk of Recurrence

312 views
October 23, 2024

Watch as Dr. Hope Rugo shares critical insights on managing and reducing the risk of HR+, HER2- breast cancer recurrence, particularly in patients with early-stage disease to better individualize treatment plans.

To access additional videos and download free resources click here.

VV-OTHR-US-DEL-3291 © 2024 Lilly USA, LLC. All Rights Reserved.

Comments are disabled for this content.